Cmax and Tmax Profiles Across Subcutaneous, Intravenous, and Intranasal Routes
How different injection routes reshape peak drug levels and timing for clinical effect.
Marcus Tully-Byrne
Features Writer
Marcus Tully-Byrne
Marcus Tully-Byrne is an Irish science writer with over two decades of experience covering pharmaceutical R&D for both specialist journals and general science outlets, beginning his career as a medicinal chemistry reporter in the late 1990s. He now anchors the site's longer investigative features on peptide therapeutics and the systemic challenges of biologics stability.
4 stories
Higher-Order Structure Characterization of Therapeutic Peptides
Peptides need their own structural analysis toolkit to ensure they fold correctly and work as drugs.
Marcus Tully-Byrne
Accelerated Stability Testing Protocols for Peptide Drug Products
A map of four chemical degradation pathways guides stability study design for peptides.
Marcus Tully-Byrne
Nanoparticle Encapsulation as a Peptide Stability Strategy
Nanoparticles shield peptides from degradation and control when they reach their targets.
Marcus Tully-Byrne